|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：A710502 |
| 產(chǎn)品名稱：Apadenoson-d5 |
| 產(chǎn)品CAS： |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
A710502 |
| 名稱: |
Apadenoson-d5 |
| 別名: |
trans-4-[3-[6-Amino-9-[N-(ethyl-d5)-β-D-ribofuranuronamidosyl)]-9H-purin-2-yl]-2-propyn-1-yl]-cyclohexanecarboxylic Acid Methyl Ester; ATL 146e-d5; BMS 068645-d5; DWH 146e-d5; |
| 備用CAS: |
250386-15-3-未標(biāo)記 |
| 分子式: |
C??H??D?N?O? |
| 外觀: |
白色至Light Beige Solid |
| 熔點(diǎn): |
183-188°C (dec.) |
| 分子量: |
491.55 |
| 儲(chǔ)存: |
-20ËšC Freezer, Under Inert Atmosphere |
| 溶解度: |
Methanol |
| 類別: |
Standards; Chiral Molecules; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
An A2A adenosine receptor agonist. Adjunct to nuclear myocardial perfusion imaging in patients unable to exercise adequately. |
| 文獻(xiàn) |
|
|
|
|
|
|
?您的位置：
